DCT
1:17-cv-00823
Biogen Intl GmbH v. Amneal Pharma LLC
General
Filed
06/26/17
Cause of ActionWillful Patent Infringement
SectorBiotech
Status
Closed (09/22/20)
Patent Owner
Operating Company (L)
PACER1:17-cv-00823
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
-- | 59% |
Plaintiff
Party
Name | Ratings |
|---|---|
L3C | |
L3C | |
L3C | |
L3C |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5A | |
L5A | |
L5B | |
L5B | |
L3C | |
L3D | |
L3D | |
L3D | |
L3E | |
L2-- -- | |
L5A | |
L5A | |
Ashby & GeddesLocal | L4B |
L5B | |
L4B |
Defendant
Party
Name | Ratings |
|---|---|
L4E | |
L1D | |
---- -- | |
L5E | |
L5E | |
L5E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L3E | |
L3E | |
L3E | |
L3E | |
L3E | |
L3E | |
L2C | |
L2E | |
L2E | |
L2E | |
L2E | |
L2E | |
L1C | |
L1D | |
L1E | |
L1E | |
L1E | |
L1E | |
L1E | |
L1E | |
---- -- | |
---- -- | |
---- -- | |
---- -- |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5A | |
---- -- | |
---- -- | |
L5A | |
L5B | |
L5C | |
L5D | |
L4C | |
L2C | |
L5B | |
L5E | |
L5E | |
L4E | |
L3E | |
L2-- -- | |
L1B | |
L5B | |
L5E | |
L5E | |
L5E | |
L4D | |
L4E | |
L4E | |
L3D | |
L4B | |
L5C | |
L5E | |
L4C | |
L4E | |
L4E | |
L4B | |
L5E | |
L4E | |
L4B | |
L5A | |
L5B | |
L4B | |
L3B | |
L4B | |
L5A | |
L5D | |
L5E | |
L3E | |
L4B | |
L5E | |
L4B | |
L5E | |
L4D | |
L4C | |
L4A | |
L4D | |
L4D | |
L2B | |
L4D | |
L5E | |
L5E | |
L4D | |
L4E | |
L4E | |
Bayard PALocal | L4E |
L5E | |
L3E | |
L4E | |
L5E | |
L4E | |
L3B | |
L5E | |
L3E | |
L3B | |
L3B | |
L3C | |
L5C | |
L4B | |
L3D | |
L3C | |
L5C | |
L4C | |
L4C | |
L4D | |
L3D | |
L3E | |
L2D | |
L1D | |
L3E | |
L4E | |
L3E | |
L3E | |
L3E | |
L5E | |
L5E | |
L4E | |
L3D | |
L3E | |
L3E | |
L5B | |
L5E | |
L4C | |
L3C | |
Amin HallihanLocal | L1B |
L1-- -- | |
L1D | |
L4B | |
L3D | |
---- -- | |
L1D | |
L4D | |
L1E | |
L4B | |
L1E | |
L5C | |
L5D | |
L1-- -- | |
L1C | |
L1-- -- | |
L1-- -- |